Ehrlichia canis infection in dogs can manifest with clinical signs related to bleeding and also commonly causes thrombocytopenia, particularly in the acute phase of infection. 1, 2 The exact mechanisms of bleeding and thrombocytopenia are unknown but thought to be related to processes such as vasculitis and immune and nonimmune processes affecting platelets. 3 For example, several studies have documented antiplatelet antibodies in dogs with ehrlichiosis. [4] [5] [6] [7] [8] [9] Platelet dysfunction in infected dogs with antiplatelet antibodies also has been identified and 1 study proposed that these antibodies may interfere with primary hemostasis thus contributing to bleeding events. 3, 10 Despite these processes, not all dogs infected with E. canis show signs of bleeding. 1 Currently, it is not clear why some dogs show signs of bleeding whereas other dogs do not despite clinically relevant thrombocytopenia. We hypothesize that platelets become activated during infection, blood clots become resistant to fibrinolysis or both, factors that could prevent a bleeding phenotype. A study in dogs naturally infected with
Babesia rossi identified the presence of large activated platelets based on hematologic platelet indices. This finding was theorized to contribute to the lack of bleeding seen in dogs despite severe thrombocytopenia. 11 Another study in dogs showed that systemic inflammation is associated with decreased fibrinolytic activity as determined by thromboelastography (TEG). 12 This situation could help prevent bleeding events in dogs affected by an inflammatory disease such as ehrlichiosis.
Therefore, the purpose of our study was to assess platelet indices of activation, platelet function as assessed by whole blood impedance platelet aggregometry, percentage of immunoglobulin associated platelets (percent IgG), and TEG measurements including velocity curve (Vcurve) variables in dogs experimentally infected with E. canis.
| M A TE RI A L S A ND M E TH ODS

| Experimental E. canis infection
This prospective study was approved by the Institutional Animal Care and Use Committee and used 4 healthy purpose-bred beagles and 1 client-owned dog that was clinically normal, but positive for E. canis DNA in blood 13 and Ehrlichia spp. antibodies in serum (SNAP 4Dx Plus, IDEXX Laboratories, Westbrook, Maine). The beagles were castrated males with a weight range of 13.8-15.7 kg and age range of [21] [22] [23] months at the start of the study. The beagles were housed under the same conditions, were not receiving any medications, and did not have a history of previous medication administration. Samples from all 4 dogs were tested initially and at each week (week 1-8) for antibodies against Anaplasma spp., Borrelia burgdorferi, and E. canis/E. ewingii, antigens of Dirofilaria immitis, and DNA of Anaplasma spp., Babesia spp., Bartonella spp., Ehrlichia spp., the hemoplasmas, Neorickettsia spp., and Rickettsia spp. (SNAP 4Dx Plus, IDEXX Laboratories; Veterinary Diagnostic Laboratory, Colorado State University, Fort Collins, Colorado). 13 A total of 8 mL of anticoagulated blood was collected from the client-owned E. canis-infected dog and all 4 of the E. canis-naïve dogs were each given 2 mL of this blood IV via the cephalic vein. After inoculation, the dogs were observed daily for clinical abnormalities and blood samples were scheduled to be collected on weeks 1-8. 
| Thromboelastography
For TF-TEG, citrated blood samples were allowed to sit at room temperature for 30 minutes before analysis. Briefly, the cups were warmed to 378C and 20 mL of 0. 
| Direct flow cytometry assay for plateletassociated immunoglobulin
The protocol used for our study was modified from other protocols previously described in the literature. healthy beagles before inoculation with E. canis. All samples were analyzed using a Cyan ADP instrument (Cyan ADP instrument, Beckman
Coulter, Miami, Florida) and the generated data was analyzed using
FlowJo software (FlowJo software, Tree Star, Ashland, Oregon).
| Statistical analysis
For each response variable, a repeated measures analysis (1-way ANOVA) was performed using the lme4 and lmerTest packages in R (R package, version 3.2.2). To account for repeated measures, dog was included as a random effect. Time points were compared with week 0
Journal of Veterinary Internal Medicine | 3 using Dunnett's method with the lsmeans package in R (R package, version 3.2.2). To investigate the effects of doxycycline on the measured variables, an additional analysis was performed where time points were compared with week 3 using Dunnett's method with the lsmeans package in R (R package, version 3.2.2). For all tests, a P < .05 was considered significant.
| R E SULTS
No complications were observed after the inoculations. All dogs inocu- The repeated measures 1-way ANOVA for the TF-TEG, TF 1 tPA-TEG, and whole blood impedance platelet aggregometry identified statistical differences for all variables with the exception of the fibrinolysis value MRL and the platelet aggregometry value, AUC saline . Note that TEG in dogs can be performed using an activator (eg, TF, kaolin) or without an activator (native); however, it is recommended to use an activator such as TF or kaolin. 15 Tissue factor was chosen as the activator for our study because the reference ranges used at our institution are based on TF-activated TEG analyses.
Several statistically significant differences from baseline were identified in all dogs for TEG and platelet aggregometry at multiple time points (Table 1) TMRL, and L as compared with baseline at the respective time points (Table 1) . After doxycycline administration on day 24, several statistical differences were noted as compared to week 3 (Table 1) For platelet aggregometry, no significant differences were identified in the values for AUC saline as compared with baseline or week 3.
However, the AUC ADP and AUC AA were significantly lower than baseline at the respective time points ( 
| D ISC USSION
Ehrlichia canis infects dogs worldwide and clinical manifestations can include bleeding but it is unknown why some dogs do not exhibit signs of hemorrhage despite clinically relevant thrombocytopenia. 1 Overall, we found using coagulation testing that the dogs became hypercoagulable and hypofibrinolytic based on TEG after becoming infected with E. canis. Additionally, certain measures of platelet activation increase during infection, including during the thrombocytopenic phase.
The results from TF-TEG and TF 1 tPA-TEG showed that experimentally inoculated dogs appeared hypercoagulable as compared with baseline as defined by a higher MA value and hypofibrinolytic as defined by a lower LY30 and LY60 and a higher CL30 and CL60. weeks after doxycycline administration. The velocity curve variables are generated from the TEG tracing and represent the first derivative of the associated waveform. These variables provide information regarding clot formation and clot breakdown. 16 The MRTG reflects the maximal velocity of increase in clot strength and observed clot growth whereas TMRTG reflects the time interval required to reach maximal rate of clot formation. 17, 18 Total thrombus generated reflects amount of clot strength produced and represents total area under the velocity and week 5 (increased TG) and these changes persisted and did not return to baseline until week 8. The cumulative findings from both TEG analyses and from velocity curve results indicated that dogs were hypercoagulable and hypofibrinolytic at certain time points over the course of infection and that these changes persisted for variable amounts of time after doxycycline administration. 16 A hypercoagulable and hypofibrinolytic state could result in a hemostatic phenotype rather than a bleeding phenotype, which could help explain why bleeding may not be observed in dogs infected with E. canis despite severe thrombocytopenia.
The overall function of platelets also could explain why bleeding is or is not observed in E. canis infection. If platelets are in an activated state, they will function in primary hemostasis to prevent bleeding. 21 However, if a thrombocytopathy is present, bleeding may be observed regardless of the platelet count, but particularly if the platelet count is low. We investigated platelet function using both whole blood impedance aggregometry and parameters measured on the Advia 120 hematology analyzer. The platelet aggregometry was normal except for time periods when the dogs were thrombocytopenic. Significant decreases in platelet count were observed by week 1 and remained statistically lower than baseline until week 4 and similarly, AUC ADP and AUC AA were statistically lower than baseline at weeks 2 and 3. Additionally, the initiation of doxycycline administration between weeks 3 and 4 likely affected the platelet count and resultant AUC readings. 22 The results show that platelet count returned to baseline by week 5 ( Figure 2 ) and AUC returned to baseline by weeks 4 and 5, approximately 1-2 weeks after doxycycline administration. Therefore, no evidence of platelet dysfunction was detected before thrombocytopenia was documented or once the platelet count started to rebound and normalize. Additionally, platelet activation parameters were increased. Therefore, another reason why dogs infected with E. canis may not show evidence of bleeding despite severe thrombocytopenia is if platelets are in an activated state.
Variables indicating increased platelet activity include increased MPV, MPM, and PCDW and decreased MPC. 11 These changes occur in the platelet because of release of intracellular components such as dense granules in addition to morphology changes in their integral shape.
11
Based on our results and aforementioned indices, there was evidence of platelet activation at weeks 2, 3, and 4 (increased MPV) and at weeks 1, 2, 3, and 4 (increased MPM) as compared with baseline. After doxycycline administration, MPV and MPM returned to baseline and were statistically different when results from week 3 and week 5 were compared.
The dogs were noted to have significant decreases from their baseline platelet counts during weeks 1, 2, and 3 and had platelet counts that ranged from 20 to 100 3 10 3 /mL. Therefore, there was evidence of platelet activation during the periods of most severe thrombocytopenia, but it is also plausible that these changes could have been related to increased platelet release from the bone marrow as a response to thrombocytopenia. The differentiation between these 2 possibilities was not possible in our study. Because there was evidence of potential platelet activation during these time periods, such a situation could have contributed to why no bleeding events were observed despite the dogs having significant thrombocytopenia.
Possible causes for thrombocytopenia and subsequent bleeding in E. canis infected dogs include destruction of platelets by plateletdirected antibodies, increased clearance of platelets from circulation by the spleen and sequestration as a result of vasculitis. [4] [5] [6] [7] 9, 23 The percent IgG was statistically higher than baseline at week 3 but statistically significant thrombocytopenia also was identified at weeks 1, 2, and 3.
This finding is in agreement with other studies in which the thrombocytopenia observed in E. canis infections likely was caused by several mechanisms and not solely platelet-directed antibodies. Interestingly, the percent IgG decreased after administration of doxycycline in all dogs and they all were considered negative by week 5 ( Figure 2 ). This finding was surprising because the half-life of most of the immunoglobulin G (IgG) subclasses in dogs is estimated to be similar to that of humans, which is approximately 20-21 days. Four subclasses of IgG occur in both humans and dogs, but they are categorized differently.
24
A previous study reported that natural and experimental E. canis infections in dogs are associated with a predominance of IgG2 rather than IgG1. 25 Immunoglobulin G2 is the functional human analog to the canine IgG subclass A which is not thought to be involved in antibodydependent cell-mediated cytotoxicity or complement-dependent cytotoxicity, but research is ongoing to better characterize the canine IgG subclasses. 24 The rapid decrease in percent IgG after doxycycline may be related to other nonantimicrobial effects of this drug. For example, it has been previously documented that dogs infected with E. canis and healthy dogs had an increase in platelet counts suggesting that doxycycline may result in platelet proliferation. 22 Additionally, doxycycline has been shown to decrease antibody production and inhibit proliferating lymphocytes. 22, 26 It also has been shown to decrease the expression of IgG on granulocytes, but it is unknown if this occurs with platelets. Another notable finding observed during our study was that all of the dogs were strongly positive on serology (SNAP 4Dx Plus, IDEXX Laboratories Inc) testing for Ehrlichia spp. at week 1 but were PCR negative. At week 2, all dogs exhibited a weak positive result by serology (SNAP 4Dx Plus, IDEXX Laboratories Inc) testing but all were PCR positive. Then, at week 3, 2 of the dogs were negative and 2 dogs were positive on serology testing. Not until week 6 were all dogs noted to be serology positive again. Experimentally infected dogs can become seropositive to E. canis as early as 7 days postinoculation, but seropositivity may not be seen for 28 days postinoculation. 1 We suspect that the strong positive results initially seen in all 4 dogs were actually antibodies transferred passively from the E. canis positive donor blood.
This would also explain why the subsequent weeks showed a weak positive result, which transitioned into a negative result in 2 of the dogs. Because we suspect the dogs were not only inoculated with E.
canis positive blood but also with antibodies against E. canis from the donor dog, this also could explain the relatively delayed conversion to seropositivity in some of the dogs.
Dogs infected with E. canis have been shown previously to have decreased platelet function based on several platelet aggregation studies, 3, 10 but to our knowledge, no studies have been performed using multiple channel electrical impedance platelet aggregometry. However, when using impedance platelet aggregometry, decreased platelet counts and a high HCT can cause in vitro effects on platelet aggregometry resulting in lower AUC readings. [28] [29] [30] As a result, AUC readings may appear erroneously low because of thrombocytopenia rather than reflecting true platelet dysfunction. To address this, an alternative technique is to standardize the platelet count in all samples before performing aggregometry. Doing so requires manipulation of the platelets (centrifugation) and the test is not performed in whole blood which may not reflect the true changes occurring in vivo (in whole blood).
3,10
Our testing was performed using whole blood, and the platelet count was not adjusted. As a result, the observed AUC readings likely were affected by the significant changes in platelet count and HCT observed at certain time points, which is a limitation of the study.
There were several other limitations to this study not previously mentioned. The primary limitation was use of blood from a naturally infected dog to initiate E. canis infection rather than tick infestation. It currently is unknown whether factors imparted by Rhipicephalus sanguineus could result in different findings to those obtained by inoculation of whole blood from a naturally infected dog or cell culture-derived E.
canis. However, evaluation of the coagulation system using TEG has not previously been performed in dogs experimentally or naturally infected with E. canis, and thus an experimental model initially was investigated. In addition, the clinical, laboratory, and treatment responses to doxycycline occurred in all dogs and were similar to those findings reported with naturally occurring infection, suggesting that our findings are valid. 1 However, our results should be confirmed in naturally infected dogs or dogs infested experimentally with R. sanguineus that carry E. canis. Another potential limitation is that the naturally infected donor dog blood used to initiate E. canis infection could have contained other infectious agents that could have affected the results.
However, we believe this is unlikely because the dogs tested negative several times for other known causes of thrombocytopenia. This limitation also could occur when naturally infected dogs are studied or wildcaught R. sanguineus are used to initiate infections. A final limitation is the small number of dogs that were used. Thus, whether these findings are clinically relevant is unknown and additional studies are warranted.
Although the mechanisms of thrombocytopenia and bleeding are not completely understood in dogs infected with E. canis, our results
showed that activated platelets and a hypercoagulable, hypofibrinolytic state may explain the lack of a bleeding phenotype in some dogs despite substantial thrombocytopenia. Additionally, further studies are needed to investigate the relationship between doxycycline administration and platelet dynamics in thrombocytopenic dogs.
